EP1404291B1 - Wasserfreies ubichinon-konzentrat - Google Patents
Wasserfreies ubichinon-konzentrat Download PDFInfo
- Publication number
- EP1404291B1 EP1404291B1 EP02743249A EP02743249A EP1404291B1 EP 1404291 B1 EP1404291 B1 EP 1404291B1 EP 02743249 A EP02743249 A EP 02743249A EP 02743249 A EP02743249 A EP 02743249A EP 1404291 B1 EP1404291 B1 EP 1404291B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- weight units
- coenzyme
- concentrate
- water
- mixture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
- A61K8/355—Quinones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/86—Polyethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dispersion Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Emergency Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Toxicology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Confectionery (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10133305A DE10133305B4 (de) | 2001-07-12 | 2001-07-12 | Ubichinon Konzentrat |
DE10133305 | 2001-07-12 | ||
PCT/EP2002/007195 WO2003007907A1 (de) | 2001-07-12 | 2002-06-29 | Wasserfreies ubichinon-konzentrat |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1404291A1 EP1404291A1 (de) | 2004-04-07 |
EP1404291B1 true EP1404291B1 (de) | 2008-09-24 |
Family
ID=7691172
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP02743249A Expired - Lifetime EP1404291B1 (de) | 2001-07-12 | 2002-06-29 | Wasserfreies ubichinon-konzentrat |
Country Status (13)
Country | Link |
---|---|
US (1) | US7094804B2 (es) |
EP (1) | EP1404291B1 (es) |
JP (1) | JP2004534853A (es) |
CN (1) | CN1545406A (es) |
AT (1) | ATE409022T1 (es) |
CA (1) | CA2453473A1 (es) |
DE (3) | DE20122900U1 (es) |
DK (1) | DK1404291T3 (es) |
ES (1) | ES2315370T3 (es) |
HK (1) | HK1067297A1 (es) |
MX (1) | MXPA04000349A (es) |
RU (1) | RU2287981C2 (es) |
WO (1) | WO2003007907A1 (es) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE20122900U1 (de) | 2001-07-12 | 2009-12-03 | Aquanova Ag | Ubichinon Konzentrat |
JP4234674B2 (ja) | 2002-05-22 | 2009-03-04 | ユニリーバー・ナームローゼ・ベンノートシヤープ | 化粧品組成物を調製する方法、およびこの方法により調製した化粧品組成物 |
DE10243437A1 (de) * | 2002-09-18 | 2004-04-29 | Pm-International Ag | Kosmetische Formulierung |
US20060251637A1 (en) * | 2003-03-11 | 2006-11-09 | Toshinori Ikehara | Oil-in-water type emulsion containing coenzyme q10 and process for producting the same |
JP2006519796A (ja) * | 2003-03-12 | 2006-08-31 | ユニリーバー・ナームローゼ・ベンノートシヤープ | 濃縮物からパーソナルケア組成物を製造する方法 |
US20070043106A1 (en) * | 2005-08-18 | 2007-02-22 | Dariush Behnam | Alpha-lipoic acid concentrate |
WO2006018301A1 (de) * | 2004-08-18 | 2006-02-23 | Aquanova German Solubilisate Technologies (Agt) Gmbh | Liponsäure-konzentrat |
JP5147239B2 (ja) * | 2004-09-29 | 2013-02-20 | 三栄源エフ・エフ・アイ株式会社 | コエンザイムq10含有乳化組成物 |
AU2004326297B2 (en) * | 2004-11-16 | 2008-08-07 | Bioavailability, Inc. | High concentration self-microemulsifying coenzyme Q10 preparations for nutritional use |
DE102006010809B4 (de) * | 2006-03-07 | 2009-10-22 | Aquanova Ag | Solubilisat eines Konservierungsmittels |
US8491888B2 (en) * | 2006-05-05 | 2013-07-23 | Softgel Formulators, Inc. | Highly absorbable coenzyme Q10 composition and method of producing same |
MY153288A (en) * | 2006-06-28 | 2015-01-29 | Hovid Berhad | An effective pharmaceutical carrier for poorly bioavailable drugs |
JP5028885B2 (ja) * | 2006-07-04 | 2012-09-19 | 大正製薬株式会社 | ユビデカレノン含有自己乳化組成物 |
EP2066310B1 (de) * | 2006-09-22 | 2012-04-18 | Mivital AG | Emulsionen enthaltend gummi arabicum |
US20080145411A1 (en) * | 2006-10-06 | 2008-06-19 | Kaneka Corporation | Composition of high absorbability for oral administration comprising oxidized coenzyme q10 |
WO2008138155A2 (de) * | 2007-05-09 | 2008-11-20 | Mivital Ag | Emulsionsvorkonzentrate sowie micellare formulierungen enthaltend wurzelharz |
US20090130198A1 (en) * | 2007-11-21 | 2009-05-21 | Innopharmax Inc. | Pharmaceutical composition with enhanced bioavailability |
WO2009117151A2 (en) * | 2008-03-20 | 2009-09-24 | Virun, Inc. | Compositions containing non-polar compounds |
WO2009117152A1 (en) | 2008-03-20 | 2009-09-24 | Virun, Inc. | Emulsions including a peg-derivative of tocopherol |
US8337931B2 (en) * | 2008-06-23 | 2012-12-25 | Virun, Inc. | Compositions containing non-polar compounds |
CH699449A2 (de) * | 2008-08-27 | 2010-03-15 | Mivital Ag | Emulsionsvorkonzentrate sowie micellare Formulierungen enthaltend Glycerinfettsäureester. |
US8445037B2 (en) * | 2008-10-28 | 2013-05-21 | A. M. Todd Company | Volatile distillate by-product of mint oil that promotes absorption and/or bioavailability of compounds of bio-medical and nutritional interest |
US9005608B2 (en) * | 2009-03-24 | 2015-04-14 | Adds Pharmaceuticals Llc | Stabilized solubility-enhanced formulations for oral delivery |
DE102009025215A1 (de) | 2009-06-17 | 2010-12-30 | Carl Zeiss Vision Gmbh | Methode und Vorrichtung zur Ermittlung der habituellen Kopfhaltung |
EP2544663B1 (en) | 2010-03-12 | 2018-01-03 | Berg LLC | Intravenous formulations of coenzyme q10 (coq10) and methods of use thereof |
WO2011119228A1 (en) * | 2010-03-23 | 2011-09-29 | Virun, Inc. | Nanoemulsion including sucrose fatty acid ester |
US8741373B2 (en) | 2010-06-21 | 2014-06-03 | Virun, Inc. | Compositions containing non-polar compounds |
MY183615A (en) | 2011-06-17 | 2021-03-03 | Berg Llc | Inhalable pharmaceutical compositions |
EP2811847B1 (en) | 2012-02-10 | 2017-12-13 | Virun, Inc. | Beverage compositions containing non-polar compounds |
EP2852379A4 (en) * | 2012-05-22 | 2015-11-04 | Laila Pharmaceuticals Pvt Ltd | NEW NANOFORMULATIONS OF COMPOUNDS AND EXTRACTS DERIVED FROM HYDROPHOBIC, HIGHLY BIOAVAILABLE, WATER SOLUBLE AND EXTENDED RELEASE PLANTS |
JP5722299B2 (ja) * | 2012-12-07 | 2015-05-20 | バイオアバイラビリティ,インク. | 栄養学的に使用するための高濃度自己マイクロエマルジョン化コエンザイムq10調製物 |
JP5999765B2 (ja) * | 2012-12-07 | 2016-09-28 | バイオアバイラビリティ,インク. | 栄養学的に使用するための高濃度自己マイクロエマルジョン化コエンザイムq10調製物 |
DE202012012130U1 (de) | 2012-12-19 | 2014-03-21 | Aquanova Ag | Curcuminsolubilisat |
US9351517B2 (en) | 2013-03-15 | 2016-05-31 | Virun, Inc. | Formulations of water-soluble derivatives of vitamin E and compositions containing same |
US9861611B2 (en) | 2014-09-18 | 2018-01-09 | Virun, Inc. | Formulations of water-soluble derivatives of vitamin E and soft gel compositions, concentrates and powders containing same |
AU2016324349A1 (en) * | 2015-09-17 | 2018-02-15 | Pharmako Biotechnologies Pty Limited | Ubiquinone and ubiquinol compositions, and methods relating thereto |
EP3290026A1 (en) | 2016-09-06 | 2018-03-07 | Athenion AG | Method for solubilizing poorly water-soluble dietary supplements and pharmaceutically active agents |
EP3511325A1 (en) * | 2018-01-11 | 2019-07-17 | MetrioPharm AG | Method for solubilizing 5-amino-2,3-dihydro-1,4-phthalazinedione |
EP3536332A1 (en) | 2018-03-07 | 2019-09-11 | Athenion AG | Krill oil for solubilizing poorly water-soluble dietary supplements and pharmaceutically active agents |
EP3919046A1 (en) | 2020-06-02 | 2021-12-08 | Athenion AG | Method for solubilizing natural, endogenous and synthetic cannabinoids |
EP4186497A1 (en) | 2021-11-26 | 2023-05-31 | Dorian Bevec | Alpha lipoic acid, epigallocatechin 3-gallate, and curcumin as a medicament for the treatment of arthritis or sars-cov-2 infection |
WO2023199908A1 (ja) * | 2022-04-11 | 2023-10-19 | 株式会社ダイセル | 乳化組成物の製造方法 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5581813A (en) * | 1978-12-16 | 1980-06-20 | Nisshin Flour Milling Co Ltd | Composition containing coenzyme q10 and its perparation |
JPS5618914A (en) | 1979-07-25 | 1981-02-23 | Eisai Co Ltd | Ubidecarenone composition having good absorbability |
DE3224619A1 (de) * | 1981-07-14 | 1983-05-19 | Freund Industrial Co., Ltd., Tokyo | Orale pharmazeutische zusammensetzung |
JPS60199814A (ja) | 1984-03-24 | 1985-10-09 | Taisho Pharmaceut Co Ltd | ユビデカレノン脂肪乳剤 |
EP0179583A1 (en) | 1984-10-04 | 1986-04-30 | Merck & Co. Inc. | A system for enhancing the water dissolution rate and solubility of poorly soluble drugs |
JPS61221131A (ja) * | 1985-03-28 | 1986-10-01 | Eisai Co Ltd | 吸収促進したユビデカレノン含有組成物 |
JPS62123113A (ja) | 1985-11-22 | 1987-06-04 | Green Cross Corp:The | ユビデカレノン含有脂肪乳剤 |
IT1263840B (it) * | 1993-03-30 | 1996-09-04 | Giuseppe Furiosi | Formulazioni orali di ubidecarenone in forma di capsule |
US6056971A (en) * | 1996-07-24 | 2000-05-02 | Biosytes Usa, Inc. | Method for enhancing dissolution properties of relatively insoluble dietary supplements and product incorporating same |
DE19647352C2 (de) | 1996-11-15 | 2000-06-29 | Aqua Nova Getraenketechnologie | Nicht alkoholisches Getränk mit einem Gehalt an Q 10 |
US6200550B1 (en) * | 1998-12-11 | 2001-03-13 | Q-Pharma, Inc. | Oral care compositions comprising coenzyme Q10 |
US8753675B1 (en) * | 2000-01-20 | 2014-06-17 | Raj K. Chopra | Reduced form of Coenzyme Q in high bioavailability stable dosage forms and related applications |
DE10104847B4 (de) * | 2000-06-09 | 2006-12-21 | Aquanova German Solubilisate Technologies (Agt) Gmbh | Tocopherol-Konzentrat und Verfahren zu seiner Herstellung |
US6300377B1 (en) * | 2001-02-22 | 2001-10-09 | Raj K. Chopra | Coenzyme Q products exhibiting high dissolution qualities |
DE50100901D1 (de) | 2001-04-12 | 2003-12-11 | Vesifact Ag Baar | Coenzym Q10 enthaltende Mikroemulsion-Prekonzentrate und Mikroemulsionen |
DE20122900U1 (de) | 2001-07-12 | 2009-12-03 | Aquanova Ag | Ubichinon Konzentrat |
-
2001
- 2001-07-12 DE DE20122900U patent/DE20122900U1/de not_active Expired - Lifetime
- 2001-07-12 DE DE10133305A patent/DE10133305B4/de not_active Revoked
-
2002
- 2002-06-29 AT AT02743249T patent/ATE409022T1/de active
- 2002-06-29 EP EP02743249A patent/EP1404291B1/de not_active Expired - Lifetime
- 2002-06-29 CA CA002453473A patent/CA2453473A1/en not_active Abandoned
- 2002-06-29 DK DK02743249T patent/DK1404291T3/da active
- 2002-06-29 RU RU2004103975/15A patent/RU2287981C2/ru active
- 2002-06-29 ES ES02743249T patent/ES2315370T3/es not_active Expired - Lifetime
- 2002-06-29 CN CNA028140192A patent/CN1545406A/zh active Pending
- 2002-06-29 US US10/276,328 patent/US7094804B2/en not_active Expired - Lifetime
- 2002-06-29 MX MXPA04000349A patent/MXPA04000349A/es active IP Right Grant
- 2002-06-29 DE DE50212809T patent/DE50212809D1/de not_active Expired - Lifetime
- 2002-06-29 JP JP2003513516A patent/JP2004534853A/ja active Pending
- 2002-06-29 WO PCT/EP2002/007195 patent/WO2003007907A1/de active IP Right Grant
-
2004
- 2004-10-07 HK HK04107718.2A patent/HK1067297A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
MXPA04000349A (es) | 2005-03-07 |
RU2004103975A (ru) | 2005-03-27 |
DK1404291T3 (da) | 2009-02-02 |
JP2004534853A (ja) | 2004-11-18 |
DE10133305B4 (de) | 2004-06-03 |
RU2287981C2 (ru) | 2006-11-27 |
DE20122900U1 (de) | 2009-12-03 |
CA2453473A1 (en) | 2003-01-30 |
DE10133305A1 (de) | 2003-02-13 |
CN1545406A (zh) | 2004-11-10 |
US20030165438A1 (en) | 2003-09-04 |
DE50212809D1 (de) | 2008-11-06 |
EP1404291A1 (de) | 2004-04-07 |
WO2003007907A1 (de) | 2003-01-30 |
US7094804B2 (en) | 2006-08-22 |
ES2315370T3 (es) | 2009-04-01 |
HK1067297A1 (en) | 2005-04-08 |
ATE409022T1 (de) | 2008-10-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1404291B1 (de) | Wasserfreies ubichinon-konzentrat | |
DE69632745T2 (de) | Zusatznahrung für kindpatienten | |
DE3926658C2 (de) | Fettsäurezusammensetzung | |
DE60026611T2 (de) | Trinkbare omega-3-zubereitung | |
EP1799204B1 (de) | Omega-3-fettsäuren und omega-6-fettsäuren enthaltende zusammensetzung | |
EP1338271B1 (de) | Wässrige Lösung von Ascorbinsäure | |
EP1475083B1 (de) | Verfahren zur Herstellung eines Wirkstoffkonzentrats sowie Wirkstoffkonzentrat | |
JPH11514221A (ja) | 新規プロセス | |
US10071030B2 (en) | Carrier comprising non-neutralised tocopheryl phosphate | |
DE3151245A1 (de) | Zur enteralen ernaehrung geeignete nahrungszusammensetzung | |
EP2066310B1 (de) | Emulsionen enthaltend gummi arabicum | |
DE10130491A1 (de) | Verwendung von mittelkettigen Triglyceriden zur Prävention und Therapie von Adipositas | |
DE4405545A1 (de) | Fettlösliche Vitamine enthaltende Zubereitung zur oralen Applikation | |
EP1781119A1 (de) | Liponsäure-konzentrat | |
DE10104847B4 (de) | Tocopherol-Konzentrat und Verfahren zu seiner Herstellung | |
DE19630789A1 (de) | Physiologisch wirksame Mengen beta-Carotin-enthaltende klare wäßrig-alkoholische Multivitamin-Lösung | |
EP3473240B1 (de) | Eine im wesentlichen wasserfreie zusammensetzung, insbesondere zur verwendung als nahrungsergänzungsmittel | |
EP2142015A2 (de) | Emulsionsvorkonzentrate sowie micellare formulierungen enthaltend wurzelharz | |
JPH0717860A (ja) | 脂溶性物質含有液剤および脂溶性物質の乳化・可溶化方法 | |
DE102007056424A1 (de) | Pharmazeutische Zusammensetzung, enthaltend eine Öl/Wasser-Emulsion | |
DE19756123A1 (de) | Diätetische oder pharmazeutische Zubereitung | |
EP0141051A2 (de) | Weichgelatinekapseln enthaltend Vitamin A und E | |
WO2011147410A2 (de) | Verfahren zur herstellung eines micellaren wirkstoffkonzentrats |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20040106 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR |
|
AX | Request for extension of the european patent |
Extension state: AL LT LV MK RO SI |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1067297 Country of ref document: HK |
|
17Q | First examination report despatched |
Effective date: 20060307 |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: AQUANOVA AG |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: AQUANOVA AG |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61K 8/92 20060101ALI20080130BHEP Ipc: A61K 31/122 20060101ALI20080130BHEP Ipc: A61Q 11/00 20060101ALI20080130BHEP Ipc: A61Q 19/00 20060101ALI20080130BHEP Ipc: A61K 9/48 20060101ALI20080130BHEP Ipc: A61K 9/107 20060101ALI20080130BHEP Ipc: A61K 8/86 20060101ALI20080130BHEP Ipc: A61K 8/35 20060101AFI20080130BHEP |
|
RTI1 | Title (correction) |
Free format text: WATER-FREE UBIQUINONE CONCENTRATE |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR |
|
AX | Request for extension of the european patent |
Extension state: AL LT LV MK RO SI |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D Free format text: NOT ENGLISH |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D Free format text: LANGUAGE OF EP DOCUMENT: GERMAN |
|
REF | Corresponds to: |
Ref document number: 50212809 Country of ref document: DE Date of ref document: 20081106 Kind code of ref document: P |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: NV Representative=s name: BOVARD AG PATENTANWAELTE |
|
REG | Reference to a national code |
Ref country code: DK Ref legal event code: T3 |
|
LTIE | Lt: invalidation of european patent or patent extension |
Effective date: 20080924 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2315370 Country of ref document: ES Kind code of ref document: T3 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FD4D |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20090224 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20080924 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed |
Effective date: 20090625 |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1067297 Country of ref document: HK |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20090630 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20081224 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20081225 |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: V1 Effective date: 20110101 |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: BK Free format text: ONTERECHT VERVALLEN OP 01.01.2011PUBLIKATIE VERVAL I.E. 2011/02UITGEGEVEN 12.01.2011 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PFA Owner name: AQUANOVA AG Free format text: AQUANOVA AG#BIRKENWEG 8-10#64295 DARMSTADT (DE) -TRANSFER TO- AQUANOVA AG#BIRKENWEG 8-10#64295 DARMSTADT (DE) |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20090629 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20110101 |
|
PGRI | Patent reinstated in contracting state [announced from national office to epo] |
Ref country code: IT Effective date: 20110501 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20080924 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20080924 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: AT Payment date: 20121122 Year of fee payment: 11 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DK Payment date: 20130624 Year of fee payment: 12 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FI Payment date: 20130619 Year of fee payment: 12 Ref country code: IT Payment date: 20130624 Year of fee payment: 12 Ref country code: NL Payment date: 20130620 Year of fee payment: 12 |
|
REG | Reference to a national code |
Ref country code: DK Ref legal event code: EBP Effective date: 20140630 |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: V1 Effective date: 20150101 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20140629 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MM01 Ref document number: 409022 Country of ref document: AT Kind code of ref document: T Effective date: 20140629 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20150101 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20140629 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20140629 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20140630 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: ES Payment date: 20150629 Year of fee payment: 14 Ref country code: CH Payment date: 20150623 Year of fee payment: 14 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 15 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: BE Payment date: 20160621 Year of fee payment: 15 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20160630 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20160630 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 16 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20160630 |
|
REG | Reference to a national code |
Ref country code: BE Ref legal event code: MM Effective date: 20170630 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 17 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FD2A Effective date: 20180628 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20170630 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R082 Ref document number: 50212809 Country of ref document: DE Representative=s name: AUGSPURGER - TESCH - FRIDERICHS PATENT- UND RE, DE |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20210621 Year of fee payment: 20 Ref country code: FR Payment date: 20210621 Year of fee payment: 20 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20210623 Year of fee payment: 20 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R071 Ref document number: 50212809 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: PE20 Expiry date: 20220628 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION Effective date: 20220628 |